Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort
Crossref DOI link: https://doi.org/10.1186/s12891-017-1528-y
Published Online: 2017-04-19
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sewerin, Philipp
Vordenbaeumen, Stefan
Hoyer, Annika
Brinks, Ralph
Buchbender, Christian
Miese, Falk
Schleich, Christoph
Klein, Sabine
Schneider, Matthias
Ostendorf, Benedikt
Funding for this research was provided by:
AbbVie Deutschland (DE) (Remission-plus)